Neurotech developing a cortical visual prosthesis that restores functional vision by stimulating the brain's visual cortex.
| Date | Round | Amount |
|---|---|---|
| May 2026 | Funding round ReVision Implant (Leuven) raised 4M euros in an oversubscribed round from private investors to take its Occular cortical visual implant to its first human clinical trials in Q3 2026. | $4.6M |
Data is community-curated and may be incomplete.